This will kick the GLP-1RA revolution in a new gear.
it’s already one of the most common drug classes in the US and not having to inject and falling prices (see Novo Nodirsk’s subscription model) will help with access.
I think being able to use a pill instead of an injection will be a huge shift for many people. This will be further accelerated by Medicare offering Foundayo for $50 copay for eligible patients.
I keep a running tracker of every GLP-1 and incretin drug, approved and still in the pipeline, with what each one targets, how far along it is, and what's coming next.
See the full GLP-1 Pipeline Tracker →Get the next one in your inbox
I write about longevity, training, and preventive health weekly — without the guru worship. Free, no spam, unsubscribe whenever.
About Gunnar
Gunnar is 53. He lost about 170 pounds, trains in a garage gym, and writes DadStrengthDaily from personal experience, citing primary sources where he can. He also moderates r/ProactiveHealth. He is not a doctor, and nothing here is medical advice. Talk to your own doctor before acting on anything, especially GLP-1s, TRT, blood pressure, sleep apnea, and cancer screening.